Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions

AIIMS Bhopal has taken a historic step toward integrating Indian systems of medicine with modern healthcare through a Memorandum of Understanding (MoU) signed with the Patanjali Research Foundation Trust. This collaboration aims to promote joint research, education, and innovation by combining allopathic medical science with ancient Ayurvedic knowledge to offer comprehensive and effective healthcare solutions.

The MoU was signed in the presence of AIIMS Bhopal’s Executive Director, Prof. (Dr.) Ajai Singh, and Patanjali Research Institute’s Chief Scientist, Dr. Anurag Varshney. The partnership will focus on collaborative research in critical areas such as fatty liver disease, allergies, lifestyle-related disorders, liver ailments, respiratory issues, kidney diseases, and neurological disorders. A key point of discussion during the event was the clinical controlled trials of Patanjali’s evidence-based Ayurvedic medicines, Livogrit and Bronchom.

Prof. (Dr.) Ajai Singh highlighted that this agreement signifies a new chapter in healthcare, combining the strengths of modern medical science with traditional Indian knowledge to deliver more effective, accessible, and holistic treatment options. He also announced that the Patanjali Research Foundation Trust will establish the largest herbal garden in Madhya Pradesh within the AIIMS Bhopal campus, providing a valuable resource for research and academic pursuits.

Dr. Anurag Varshney credited the blessings of Param Pujya Swami Ramdev Ji and the inspiration of Param Shraddhey Acharya Balkrishna Ji for driving this collaboration, which he described as a significant move toward positioning Patanjali Ayurveda on the global stage.

Prof. (Dr.) Ashok Kumar, a key organizer of the event, called the initiative a milestone in India’s journey toward self-reliance and empowerment in medicine, emphasizing that it exemplifies the successful integration of modernity and ancient wisdom.

Also present at the event were AIIMS Bhopal’s Dean (Research) Prof. (Dr.) Rehan-UI-Haq, Dean (Academics) Prof. (Dr.) Rajnish Joshi, Prof. (Dr.) Ashok Kumar, and several other senior officials and scientists.

Related Posts

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

New Delhi: Improving access to new age medicines for obesity and diabetes over the next few years would be a key enabler for the growth of the domestic pharmaceutical industry,…

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 37 new drugs in its recent meeting, under the provisions of the Drugs Prices Control Order (DPCO), 2013,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Strides Pharma Science arm New York facility gets 4 USFDA observations

Strides Pharma Science arm New York facility gets 4 USFDA observations

SSI Mantra, Made in India Robot, bats a Thousand by completing 100 Telesurgeries

SSI Mantra, Made in India Robot, bats a Thousand by completing 100 Telesurgeries